Pioneering Reusable Packaging in Germany
In 2021 MSD Animal Health became the first manufacturing pharmaceutical company in Germany to implement a reusable packaging system and ship medicines and vaccines in sustainable, reusable boxes. In its quest to lessen its impact on the estimated 177.9 kg of packaging waste that each EU inhabitant generated in 2020, the company reduced its CO2 footprint by more than 50% and saved more than 80% of water by eliminating disposable packaging. In just two years, MSD Animal Health delivered one million reusable boxes in Germany. In light of its success, MSD is now working to introduce reusable boxes into shipping processes in other countries as well.
Related items
:focal())
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.